Table 3 OARs, EARs, and AERs of subsequent LBCs after other cancers.
Subsequent LBC after other cancers in all patients | Subsequent LBC after other cancers in male patients | Subsequent LBC after other cancers in female patients | |||||||
|---|---|---|---|---|---|---|---|---|---|
Absolute numbers | OARs | AERs | Absolute numbers | OARs | AERs | Absolute numbers | OARs | AERs | |
EARs | EARs | EARs | |||||||
All cancers excluding LBC | 56,479 | 27.90 | 2.73 | 34,263 | 37.86 | 2.94 | 22,216 | 19.84 | 2.55 |
25.17 | 34.92 | 17.29 | |||||||
Prostate | 12,522 | 34.96 | −9.07 | 12,522 | 34.96 | −9.07 | — | — | — |
44.03 | 44.03 | ||||||||
Breast | 8,843 | 18.53 | 0 | 94 | 37.19 | 0 | 8,749 | 18.43 | 0 |
18.53 | 37.19 | 18.43 | |||||||
Colorectum | 7,022 | 29.85 | −0.39 | 4,325 | 37.45 | −2.15 | 2,697 | 22.52 | 1.31 |
30.24 | 39.60 | 21.21 | |||||||
Urinary Bladder | 6,419 | 59.63 | 24.76 | 5,101 | 63.48 | 24.13 | 1,318 | 48.28 | 26.61 |
34.87 | 39.35 | 21.67 | |||||||
Oral Cavity and Pharynx | 3,995 | 75.15 | 49.49 | 2,918 | 84.05 | 53.67 | 1,077 | 58.40 | 41.63 |
25.66 | 30.38 | 16.77 | |||||||
Larynx | 3,037 | 131.36 | 96.90 | 2,469 | 131.18 | 93.31 | 568 | 132.16 | 112.65 |
34.46 | 37.87 | 19.51 | |||||||
Non-Hodgkin Lymphoma | 2,077 | 28.37 | 6.52 | 1,167 | 30.67 | 5.16 | 910 | 25.89 | 8.00 |
21.85 | 25.51 | 17.89 | |||||||
Corpus Uteri | 1,916 | 15.78 | −5.01 | — | — | — | 1,916 | 15.78 | −5.01 |
20.79 | 20.79 | ||||||||
Melanoma | 1,665 | 13.58 | −4.72 | 995 | 16.52 | −7.51 | 670 | 10.75 | −2.01 |
18.30 | 24.03 | 12.76 | |||||||
Kidney and Renal Pelvis | 1,320 | 28.81 | 3.54 | 893 | 32.25 | 2.03 | 427 | 23.55 | 5.83 |
25.27 | 30.22 | 17.72 | |||||||